The pharmacokinetic and tolerability profile of once-daily Zibotentan (ZD4054) in Japanese and Caucasian patients with hormone-resistant prostate cancer.

M. Ranson, Richard Wilson, Joe O'Sullivan, M. Maruoka, A. Yamaguchi, R. Cowan, J. Logue, H. Jones, N. Tominaga, H. Swaisland, S. Oliver, M. Usami

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)708-717
Number of pages10
JournalInternational Journal of Clinical Pharmacology and Therapeutics
Volume48 (11)
Publication statusPublished - Nov 2010

Cite this